Skip to main content

Not investment advice.Read full disclaimer

SONN: Sonnet BioTherapeutics Holdings, Inc. Fundamental Analysis | finqOS

Healthcare · Biotechnology

52W Range

1thpctl

Volume

9.23×avg

Market Cap

8.43MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Loading analysis data...

Continue with finqOS

Analyze Sonnet BioTherapeutics Holdings, Inc.'s fundamentals

175+ metrics with multi-year trends, CAGR calculations, and customizable analysis templates.

Start Free Trial→Sign In

14-day free trial · No credit card required

Sonnet BioTherapeutics Holdings, Inc.

SONNNASDAQ Capital Market·USD·Closed

Sonnet BioTherapeutics Holdings, Inc.

SONNNASDAQ·USD·Closed

$1.26

−59.35%

$1.26

−$1.84 (59.35%)

52W Range

1thpctl

Volume

9.23×avg

Mkt Cap

8.43MUSD

P/E

-0.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings